15 Mar
American College of Gastroenterology
Infliximab Results of a study of infliximab (Remicade, Centocor) in patients with ulcerative colitis (UC) led professor William Sandborn, MD, of the Mayo Clinic in Rochester, Minnesota, to conclude that steroid sparing should be an important goal of therapy. Although remission remains the primary goal, steroid sparing is of primary importance in terms of maintaining [...]